Dr. Lynn G Brown, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 N Wall St, Kankakee, IL 60901 Phone: 844-404-4787 Fax: 815-936-3243 |
Gaurang Gujarathi, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1710 W Court St, Kankakee, IL 60901 Phone: 815-936-3200 Fax: 815-936-3203 |
Dr. Philip G Hays, M.D Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 N Wall St Ste 303, Kankakee, IL 60901 Phone: 815-935-8040 Fax: 815-935-8569 |
Dr. Tarun Jain, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 N Wall St Ste C100, Kankakee, IL 60901 Phone: 844-404-4787 Fax: 815-936-3243 |
Abhimanyu Beri, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 N Wall St, Kankakee, IL 60901 Phone: 844-404-4787 Fax: 815-936-3243 |
Dr. Vijay M Haryani, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 500 N Wall St Ste C100, Kankakee, IL 60901 Phone: 844-404-4787 Fax: 815-936-3243 |
News Archive
3M announced today it has acquired Hybrivet Systems Inc., a leading provider of instant-read products to detect lead and other contaminants and toxins. Terms of the transaction were not disclosed.
Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.
A new study from Ohio State University provides the first laboratory evidence that certain antioxidants found in dark leafy green vegetables can indeed help prevent cataracts.
New Johns Hopkins Bloomberg School of Public Health-led research finds that blood taken from children up to the age of five contains molecular evidence about whether their mothers smoked during pregnancy.
As reported in today's Wall Street Journal, the more than 2 million Americans with atrial fibrillation are now on notice that the over-zealous marketing tactics and incentives by manufacturers of expensive medical devices which are not approved by the U.S. Food and Drug Administration (FDA) for the treatment of atrial fibrillation are likely to be influencing doctors' and hospitals' decisions about treatment for their patients' heart conditions.
› Verified 7 days ago